ArticleThe Kaohsiung journal of medical sciences2024

Correction to "miR-199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.